TERREMOTO BIOSCIENCES

Live / Applied — Fourth extension granted (statement of use) (as of 07 Aug 2025)

What this means for you

Not registered yet, but its 20 Sept 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97035846
Mark type
Stylized text
Filed
20 Sept 2021
Published for opposition
20 Jun 2023
Attorney of record
John Paul Oleksiuk

Goods and services

  • Class 005 — Pharmaceuticals: pharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceuticals for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of cancer, oncological diseases, disorders and conditions;pharmaceutical preparations and substances for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; biopharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; biopharmaceuticals for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; medicines for the prevention and treatment of cancer, oncological diseases, disorders and conditions; medicines for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; drugs for the prevention and treatment of cancer, oncological diseases, disorders and conditions;drugs for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; drug compounds for the prevention and treatment of cancer, oncological diseases, disorders and conditions;drug compounds for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; small molecules for the prevention and treatment of cancer, oncological diseases, disorders and conditions;small molecules for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; therapeutics for the prevention and treatment of cancer, oncological diseases, disorders and conditions;therapeutics for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions

Owner

Prosecution history

  • 03 Feb 2026 — SOU TEAS EXTENSION RECEIVED
  • 08 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 07 Aug 2025 — SOU EXTENSION 4 GRANTED
  • 07 Aug 2025 — SOU EXTENSION 4 FILED
  • 07 Aug 2025 — SOU TEAS EXTENSION RECEIVED
  • 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 27 Jan 2025 — SOU EXTENSION 3 GRANTED
  • 27 Jan 2025 — SOU EXTENSION 3 FILED
  • 27 Jan 2025 — SOU TEAS EXTENSION RECEIVED
  • 06 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 06 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 06 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 13 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 13 Aug 2024 — SOU EXTENSION 2 GRANTED
  • 13 Aug 2024 — SOU EXTENSION 2 FILED

View this trademark record on Marksy